Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+108.1%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
9x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 23.21% |
| 2024 | 16.83% |
| 2023 | 11.01% |
| 2022 | 2.58% |
| 2021 | -79.23% |
| 2020 | -52.94% |
| 2019 | 90.87% |
| 2018 | 0.00% |